I agree NNW. IMO, with all the patents, applications for ARTH and Dr. N.'s background in institutional investing, I really am in the camp that he's going to hold out as long as possible with all that Arch has in the bull pen with internal, ulcers and the list goes on, he will grow the company organically - Just My Opinion of course OR, he can license the technology too! - GLTU and all longs
HCIT